MiMedx Group Stock News

MiMedx Group, Inc. (NASDAQ:MDXG ) Q3 2023 Earnings Call October 30, 2023 4:30 PM ET Company Participants Matt Notarianni - Head, Investor Relations Joseph H. Capper - Chief Executive Officer Doug Rice

MiMedx Group, Inc. (NASDAQ:MDXG ) Q1 2023 Earnings Conference Call May 2, 2023 5:00 PM ET Company Participants Matt Notarianni - Head, IR Joe Capper - CEO Pete Carlson - CFO Conference Call Participan

MARIETTA, Ga., April 18, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a pioneer and leader in placental biologics, today announced that it will repor

MiMedx Group, Inc. (NASDAQ:MDXG ) Q4 2022 Results Conference Call February 28, 2023 5:00 PM ET Company Participants Matt Notarianni - Head, IR Joe Capper - CEO Pete Carlson - CFO Conference Call Parti

MiMedx Group, Inc. (NASDAQ:MDXG ) Q3 2022 Earnings Conference Call November 2, 2022 5:00 PM ET Company Participants Matt Notarianni – Head-Investor Relations Todd Newton – Interim Chief Executive

MARIETTA, Ga., Aug. 04, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced that senior mana

MiMedx Group, Inc. (NASDAQ:MDXG ) Q2 2022 Earnings Conference Call August 3, 2022 8:30 AM ET Company Participants Jack Howarth – Senior Vice President-Investor Relations Tim Wright – Chief Executi

MARIETTA, Ga., July 20, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced that it will rep

Urges Shareholders to Vote “FOR” MIMEDX’s Highly Qualified and Independent Directors – James L. Bierman and Phyllis Gardner, M.D. on the WHITE Proxy Card Today

Follows Previous Recommendation from Glass Lewis in Support of ALL Proposals

Decisive, Positive Actions Taken to Stabilize and Transform MIMEDX Have Established Strong, New Foundation for Growth

MARIETTA, Ga., May 05, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced that senior man

MARIETTA, Ga., May 05, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced that senior manag

MiMedx Group, Inc. (NASDAQ:MDXG ) Q1 2022 Earnings Conference Call May 4, 2022 8:30 AM ET Company Participants Jack Howarth - Senior Vice President, Investor Relations Tim Wright - Chief Executive Off

First Quarter Net Sales of $58.9 Million Reflects Double-Digit Revenue Increase for the Third Straight Quarter in the Company's Continuing Portfolio of Products